School of Medicine
Showing 1,251-1,300 of 1,441 Results
-
Stefanie Noel Sveiven
Postdoctoral Scholar, Critical Care Medicine
BioMy research interests include lung repair, tissue regeneration, and research models addressing underrepresented, marginalized groups. My overarching interests include promoting equity in STEM and within our communities, and environmental sustainability.
-
Ali Bin Syed
Clinical Assistant Professor, Radiology - Pediatric Radiology
BioDr. Syed is a member of the divisions of Pediatric Radiology and Body MRI and serves as the Director of MRI for Stanford Medicine Children's Health. His clinical interests include MR imaging of pediatric and adult hepatobiliary disorders, inflammatory bowel disease, gynecologic pathology, and congenital heart disease. He is also an active researcher, collaborating with fellow engineers and scientists at Stanford to translate technical innovations in MRI into improved patient care. His recent work focuses on translation of machine learning techniques for rapid, robust MRI in children and adults.
-
Holly Tabor
Professor of Medicine (Primary Care & Population Health) and, by courtesy, of Pediatrics (Stanford Center of Biomedical Ethics)
Current Research and Scholarly InterestsMy research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing and translation of genomic sequencing into the clinical setting. I also conduct research on ethical issues in clinical care and research for patients and families with autism and other developmental and cognitive disabilities.
-
Daniel Tawfik
Assistant Professor of Pediatrics (Critical Care)
Current Research and Scholarly InterestsThe Tawfik lab studies the use of electronic health record metadata in identifying structures and processes that promote high quality healthcare. Our projects apply advanced analytical methods to large databases of primarily structured electronic health record data and EHR usage metadata.
-
Joyce Teng, MD, PhD
Professor of Dermatology and, by courtesy, of Pediatrics
BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.
-
Swaraj Thaman
Life Science Research Professional, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional 1, Translational Genomics of Diabetes Laboratory, Department of Pediatrics - Endocrinology, School of Medicine
-
George F Tidmarsh
Adjunct Professor, Pediatrics - Neonatology
BioDr. Tidmarsh received M.D. and Ph.D. from Stanford University, where he also completed fellowship training in Pediatric Oncology and Neonatology and is currently Adjunct Faculty of Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years after fellowship prior to devoting his full time to clinical research and development in order to bring new treatments through the FDA approval process. Dr. Tidmarsh was President, Chief Executive Officer, Secretary and a Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. While at La Jolla, Dr. Tidmarsh helped discover the use of angiotensin II for the treatment of shock and led all aspects of the development including approval by the US FDA and the EMA for the treatment of patients suffering from distributive shock. He also led the development of artesunate for the treatment of severe malaria, now pending action for potential approval at the FDA. Dr. Tidmarsh has over 30 years of experience in biotechnology, including the successful clinical development of three FDA-approved drugs. He previously served as the Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. He also founded Threshold Pharmaceuticals, Inc. and held senior positions at Coulter Pharmaceutical, Inc. (acquired by GlaxoSmithKline) and SEQUUS Pharmaceuticals, Inc. (acquired by Johnson & Johnson). While at Coulter and SEQUUS, Dr. Tidmarsh led the clinical development of BEXXAR and Doxil, respectively, two FDA-approved anti-cancer agents.
At Stanford, Dr. Tidmarsh is devoted to teaching clinical research and development to residents, fellows and junior faculty. In addition, he is working to help improve the quality of medical care through various efforts which include serving on the board of Lucile Packard Foundation for Children's Health. -
Seda Tierney
Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsAssessment of vascular health in children by non-invasive modalities
Exercise interventions in children with congenital and acquired heart disease
Use of telehealth to deliver interventions to children with congenital and acquired heart disease
Parentally-acquired echocardiograms
Quality Improvement in Pediatric Echocardiography
Echocardiography and outcomes in congenital heart disease -
Christina (Christy) Tise, MD, PhD
Assistant Professor of Pediatrics (genetics)
BioDr. Christina (Christy) Tise is a physician scientist and Assistant Professor in the Division of Medical Genetics at Stanford with subspecialty training in Clinical Biochemical Genetics. Dr. Tise has developed multiple research projects focused on the clinical impact of biochemical genetic conditions in pregnancy and newborn health, including a project focused on unforeseen diagnoses in individuals initially identified through state newborn screening which has resulted in a number of publications.
Dr. Tise also researches the genetic etiologies of recurrent pregnancy loss and the impact of inherited metabolic conditions on human reproduction. She is involved in several research initiatives including contributing to the development of TRIOS, a multi-site, NIH-funded research study to evaluate the genetic causes of recurrent pregnancy loss. In serving as the primary research mentor for a recent Masters of Genetic Counseling graduate, Dr. Tise’s research on carrier and newborn screening has highlighted areas of ancestry-related healthcare inequities specific to the field of Medical Genetics.
Dr. Tise’s primary academic and advocacy interests are embodied in this work, specifically the overlap between biochemical and molecular analysis, and the clinical utility of innovative technologies for diagnosis and treatment of genetic disease. This is an unbelievably thrilling time for the field of Medical Genetics, as it promises immense progress and opportunity for all fields of medicine, and Dr. Tise is determined, honored, and incredibly excited to be a part of it!
Research interests: newborn screening, carrier screening, prenatal screening, genetics of recurrent pregnancy loss, biochemical genetics, novel gene discovery, variant interpretation, founder populations, diagnostic genetic testing, bioethics, GWAS/ExWAS -
Sara L. (Sally) Tobin
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsTobin is a Senior Research Scholar at the Stanford Center for Biomedical Ethics. She obtained her Ph.D. in Developmental Biology from the University of Washington and did postdoctoral research in Genetics at the University of California, Berkeley and in Biochemistry at the University of California, San Francisco. She became a faculty member at the University of Oklahoma College of Medicine in 1983 and moved to Stanford University in 1996. Her research contributions have been published in prestigious journals such as Cell, Nature, Genes & Development, Neuron, and Journal of Cell Biology.
Projects
With her collaborator, graphic designer Ann Boughton, Tobin has completed the production of three educational multimedia CD-ROM discs about the genetic revolution in medical care sparked by the rapid advances in our knowledge about the human genome. An on-line version derived and updated from these CDs is pending release through Twisted Ladder Media, and is entitled: "The New Genetics: Medicine and the Human Genome. Molecular Concepts, Applications, and Ramifications." In addition, Tobin and Boughton have collaborated on educational websites on inherited risk of breast cancer and on hereditary colorectal cancer with the Stanford Cancer Genetics Clinic.
Tobin's current major research interests include an educational project funded by the National Science Foundation to create and evaluate innovative modules for undergraduates entitled, "The New Genetics: Electronic Tools for Educational Innovation." The modules are presented in on-line form as an electronic course and are accompanied by workbook exercises and problem sets. The content includes principles of genetics, molecular genetic technologies, applications in medicine, environmental biology, agriculture, and society, as well as implications. In addition, she is collaborating on two projects that are exploring the ramifications of using genetic information about addiction risk in the judicial system.
Tobin is a member of the Benchside Consultation Team for the Center for the Integration of Research on Genetics and Ethics, and she evaluates clinical protocols for ethical issues for the Clinical Translational Research Program. -
Sarina Tom
Associate Director for Education Operations, Pediatrics
Current Role at StanfordEducation Operations Manager
Office of Pediatric Education
Stanford Department of Pediatrics -
Michael Tracy
Clinical Associate Professor, Pediatrics - Pulmonary Medicine
BioDr. Tracy is a Clinical Associate Professor in the Division of Pediatric Pulmonary. His clinical interests include care for children with bronchopulmonary dysplasia (BPD), chronic respiratory failure, mechanical ventilation, childhood interstitial lung disease, and cystic fibrosis. He serves as the director Pediatric Pulmonary BPD Program, and co-director of the Cardiac and Respiratory care for Infants with BPD (CRIB) Program. He is the medical director of the Stanford Technology Assisted Respiratory (STAR) Program and the physician lead for the inpatient Pulmonary consult service at LPCH. Dr. Tracy is currently involved in clinical research to improve care for infants with BPD. With regard to medical education, he was formerly a chief resident in pediatrics at LPCH, and served as a faculty coach in the pediatric residency program.
